Cart

0

Stocks

“These 3 Penny Stocks Have Massive Upside Potential, Says Cowen”

Neos Therapeutics (NEOS)

Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target is even more aggressive than Cacciatore’s and implies 1674% upside potential…

Dynavax Technologies (DVAX)

Other analysts echo Nadeau’s sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $16, the upside potential comes in at 276%…

La Jolla Pharmaceutical (LJPC)

What does the rest of the Street have to say? When it comes to other analyst activity, it has been relatively quiet. 2 Buys and no Holds or Sells have been issued in the last three months. Therefore, LJPC gets a Moderate Buy consensus rating. Based on the $14 average price target, shares could skyrocket 251% in the next year…”

https://finance.yahoo.com/news/3-penny-stocks-massive-upside-193058024.html

Leave a Reply